Sarepta Therapeutics, Inc. will host a webcast and conference call for the Duchenne muscular dystrophy (DMD) community on Tuesday, May 13, 2014, beginning at 11:00 am EDT (8:00 am PDT / 5:00 pm CEST).
Chris Garabedian, president and chief executive officer, and Edward Kaye, MD, chief medical officer, will provide information and answer questions about Sarepta’s DMD development program, including upcoming clinical trials. Sarepta has invited DMD community representatives from leading patient advocacy groups to participate in the question and answer portion of the webcast.
To access the webcast, follow this link to Sarepta’s website. Please connect several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.
To access only the audio portion, dial in to 1-888-895-5479 (U.S. toll free) for U.S. domestic callers or 1-847-619-6250 for international callers. The passcode for the call is 37195657. Please specify to the operator that you would like to join the “Sarepta DMD Development Program Update.”
Following the event, the webcast will be archived in the events and presentations section of Sarepta’s website for 90 days.
Questions can be submitted until noon on May 12 by emailing Alicia@cureduchenne.org (please put “Sarepta Webinar” as the subject line).